- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02335697
A Community-based Participatory Intervention to Change Attitudes Towards Female Circumcision Among Somali Immigrants in Sweden
A Community-based Participatory Intervention to Change Attitudes Towards Female Circumcision Among Somali Immigrants in Sweden: a Cluster Randomized Controlled Trial
Female circumcision (FC) causes both immediate and long-term health consequences. In general, the more severe type of FC, the worse health consequences can be seen. Despite the negative health effects, the practice of FC is still found to be highly prevalent in many countries, mainly in Africa and the Middle East. Many studies have been performed on FC in African countries where the custom is widespread and there have also been many attempts to eradicate the practice in these countries. However, considerably less research exists on FC in non-practicing societies where there has been an influx of immigrants from countries that traditionally carry out this practice. Further, no anti-FC interventions designed using a comparison group have been performed in any country outside Africa.
This cluster randomized controlled trial aims to evaluate the effectiveness of a community-based participatory intervention on changing attitudes towards FC among newly arrived Somali immigrants in Sweden. Included in the research is an assessment of the acceptability of the intervention. Based on social convention theory, we hypothesize that an interaction between established Somali immigrants, thought to be predominantly opponents of FC, and newly arrived Somali immigrants will facilitate changes in attitudes among the newly arrived.
The trial will be implemented in two municipalities in Sweden that have a high proportion of Somali immigrants. Somali organizations in these municipalities will constitute the clusters. In total, 8 clusters will be included, 4 intervention clusters and 4 control clusters.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Uppsala, Sweden, 75185
- Uppsala University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Oral informed consent
- Newly arrived (lived in Sweden for ≤ 4 years) Somali immigrants in Sweden with a residence permit
- Men and women, ≥ 18 years old
Exclusion Criteria:
- None
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: No intervention
|
|
Other: Intervention
Attitude change towards female circumcision
|
The intervention comprises of a series of meetings between newly arrived Somalis and established Somalis.
At each meeting, a pre-determined topic relating to FC will be discussed.
The topics include culture, religion, health, children's rights, and Swedish laws.
Different experts, chosen to match the specific topic of the meeting will be invited to each meeting to facilitate the interactive discussions between the participants.
Somalis who are both familiar with the Swedish and Somali culture will facilitate the meetings.
The intervention spans over a time period of six months.
The intervention meetings will be held during the first five months of the intervention period; one meeting scheduled per month.
Thereafter, there will be a 'wash-out' period of one month to allow for reflections and to minimize the risk of courtesy bias.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Visual Analogue Scale (VAS) of types of female circumcision (change in what type of female circumcision the participant thinks is acceptable to do)
Time Frame: The outcome measure will be assessed before the intervention and approximately 1-30 days after the intervention.
|
In the VAS, 0 mm indicates that no type of female circumcision is regarded as acceptable to do, and 100 mm indicates that all types of female circumcision are regarded as acceptable to do.
The outcome will be the change in what type of female circumcision the participant thinks is acceptable to do, as measured by the change from the pre-intervention score.
|
The outcome measure will be assessed before the intervention and approximately 1-30 days after the intervention.
|
Visual Analogue Scale (VAS) of types of female circumcision (change in what type of female circumcision the participant would perform if he/she had a daughter, as measured by the change from the pre-intervention score)
Time Frame: The outcome measure will be assessed before the intervention and approximately 1-30 days after the intervention.
|
In the VAS, 0 mm indicates that the participant would not perform any type of female circumcision on his/her hypothesized daughter, and 100 mm indicates that the participant would perform the most extensive type of female circumcision on his/her hypothesized daughter.
The outcome will be the change in what type of female circumcision the participant would perform if he/she had a daughter, as measured by the change from the pre-intervention score.
|
The outcome measure will be assessed before the intervention and approximately 1-30 days after the intervention.
|
The change in proportion of participants who oppose the continuation of female circumcision
Time Frame: The outcome measure will be assessed before the intervention and approximately 1-30 days after the intervention
|
The outcome measure will be assessed before the intervention and approximately 1-30 days after the intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Visual Analogue Scale (VAS) of types of female circumcision (participant assesses that Somali men in Sweden think that performing any type of female circumcision is not acceptable or acceptable)
Time Frame: The outcome measure will be assessed before the intervention and approximately 1-30 days after the intervention.
|
In the VAS, 0 mm indicates that the participant assesses that Somali men in Sweden think that performing any type of female circumcision is not acceptable, and 100 mm indicates that the participant assesses that Somali men in Sweden think performing any type of female circumcision is acceptable.
The outcome will be the change in the participant's assessment, as measured by the change from the pre-intervention score.
|
The outcome measure will be assessed before the intervention and approximately 1-30 days after the intervention.
|
Visual Analogue Scale (VAS) of types of female circumcision (participant assesses that Somali women in Sweden think performing any type of female circumcision is acceptable or not acceptable)
Time Frame: The outcome measure will be assessed before the intervention and approximately 1-30 days after the intervention.
|
In the VAS, 0 mm indicates that the participant assesses that Somali women in Sweden think performing any type of female circumcision is acceptable, and 100 mm indicates that the participant assesses that Somali women in Sweden think that performing all types of female circumcision is acceptable.
The outcome will be the change in the participant's assessment, as measured by the change from the pre-intervention score.
|
The outcome measure will be assessed before the intervention and approximately 1-30 days after the intervention.
|
Visual Analogue Scale (VAS) of number of individuals performing female circumcision
Time Frame: The outcome measure will be assessed before the intervention and approximately 1-30 days after the intervention.
|
In the VAS, 0 mm indicates that the participant assesses that no one within the Somali community in Sweden circumcise their daughters, and 100 mm indicates that the participant assesses that everybody within the Somali community in Sweden circumcise their daughters.
The outcome will be the change in the participant's assessment, as measured by the change from the pre-intervention score.
|
The outcome measure will be assessed before the intervention and approximately 1-30 days after the intervention.
|
Change in answers to questions specifically related to one of the five topics of the intervention meetings
Time Frame: The outcome measures will be assessed before the intervention and approximately 1-30 days after the intervention.
|
The outcome measures will be assessed before the intervention and approximately 1-30 days after the intervention.
|
|
Outcomes will be analyzed for associations with number of attended intervention meetings.
Time Frame: The outcome measure will be assessed approximately 1-30 days after the intervention.
|
The outcome measure will be assessed approximately 1-30 days after the intervention.
|
|
Acceptability (questionnaire will be used to collect information about acceptability of the intervention)
Time Frame: The outcome measure will be assessed approximately 1-30 days after the intervention.
|
A questionnaire will be used to collect information about acceptability of the intervention.
|
The outcome measure will be assessed approximately 1-30 days after the intervention.
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Birgitta Essén, MD, PhD, Uppsala University
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- Forte 2013-2095
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Female Circumcision
-
ProgressusUnknownCircumcision, Male | Circumcision Status: Circumcised, Uncircumcised
-
University of North Carolina, Chapel HillBill and Melinda Gates Foundation; FHI 360; Impact Research & Development OrganizationCompletedVoluntary Medical Male Circumcision | Circumcision AdultKenya
-
Damanhour Teaching HospitalCompleted
-
Assiut UniversityUnknown
-
Weill Medical College of Cornell UniversityBill and Melinda Gates FoundationCompleted
-
King Saud UniversityUnknownCircumcision, MaleSaudi Arabia
-
University of MichiganCompletedCircumcisionUnited States
-
Simunye Primary Health CareCompleted
Clinical Trials on No intervention
-
Wave NeuroscienceCompletedAutistic DisorderUnited States
-
University of Alabama at BirminghamCompletedInflammatory Bowel Diseases | Colorectal Cancer | Diverticular Diseases | Social BehaviorUnited States
-
Janssen Research & Development, LLCCompletedLupus Erythematosus, Systemic | Lupus Erythematosus, Cutaneous | Lupus Erythematosus, DiscoidUnited States, Poland
-
Hospital Universitario La Paz3MVX CCB and Agaplesion Markus Krankenhaus, Frankfurt a.M., Germany.; Department...RecruitingEmbolism | Atrial Fibrillation | Arrhythmia | Stroke, Acute | Stroke Sequelae | AblationSpain
-
Southern California College of Optometry at Marshall...Ohio State University; University of Houston; Alcon Research; University of Waterloo and other collaboratorsCompletedContact Lens Complication | Contact Lens Acute Red Eye | Contact Lens Related Corneal Infiltrate (Disorder) | Contact Lens-Induced Corneal Fluorescein StainingUnited States, Canada
-
University of Dublin, Trinity CollegeCompleted
-
Hôpital Necker-Enfants MaladesUnknown
-
China Medical University HospitalUnknownIntention to Stay, Turnover Behavior
-
University of PittsburghCompletedChronic Low Back PainUnited States